Sort
3,198 grants matching “mrna vaccine”
Vector-Borne Diseases: Biology Of Vector Host Relationship
$1,098,906Jose Ribeiro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Novel Targets for Vaccine Therapy
$1,097,667Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Immunological mechanism of muscle-localizing self-replicating RNA vaccines
$1,090,789Taishi Kimura · Hdt Bio Corporation · R01 · FY2025 · AI
Advanced tools for translation of intravenously-infused RNA LNP therapeutics to the clinic
$1,084,194John Ramunas · Rejuvenation Technologies, Inc. · R44 · FY2024 · TR
Prevention of AIDS
$1,083,056Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Multiscale Modeling of Influenza Neutralizing Antibody and Fc Effector Biology
$1,082,429Cliburn C Chan · Duke University · U01 · FY2025 · AI
CoVPN 3001 A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine LC3
$1,077,287Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Immunological mechanism of muscle-localizing self-replicating RNA vaccines
$1,074,519Taishi Kimura · Hdt Bio Corporation · R01 · FY2024 · AI
MFB: Accelerating the Discovery of Novel Liposome Formations with Origins-of-Life Insights, Laboratory Automation, and Machine Learning
$1,074,218Joshua Schrier · Fordham University · · FY2022 · MPS
Immunotherapeutic Interventions of AIDS and Cancer
$1,062,472Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Immune signatures of vaccine responses in vulnerable populations
$1,060,433Ruth R Montgomery · Yale University · U19 · FY2024 · AI
Project 2: Current Good Manufacture Practices (CGMP) Production of Nucleoside-Modified mRNAs Encoding HIV-1 Envelopes
$1,059,206Frederick Porter · Duke University · U19 · FY2019 · AI
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine
$1,046,474Amit Praful Khandhar · Hdt Bio Corporation · R61 · FY2022 · AI
Novel Targets for Vaccine Therapy
$1,039,362Claudia Palena · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Posttranscriptional control of gene expression
$1,036,045Barbara Felber · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Project 1 - Development of mRNA Immunogens for Protective Antibody Induction
$1,035,959Barton F Haynes · Duke University · U19 · FY2024 · AI
Project 1 - Development of mRNA Immunogens for Protective Antibody Induction
$1,031,297Barton F Haynes · Duke University · U19 · FY2019 · AI
DNA Vaccines
$1,031,160George N. Pavlakis · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Conserved Element DNA Vaccine
$1,021,081Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Understanding the Role of the Host Response in HIVSIV Infection
$1,020,955Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
mRNA-based chimeric membrane protein vaccination strategies directed at the MPER
$1,013,381Mikyung Kim · Dana-Farber Cancer Inst · P01 · FY2024 · AI
Autoimmunity: Mechanisms of Unresponsiveness
$1,009,020Charles Garrison Fathman · Stanford University · P01 · FY2008 · AI
CoVPN 3008 - Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
$1,007,764Myron S Cohen · Family Health International · UM1 · FY2023 · AI
Autoimmunity: Mechanisms of Unresponsiveness
$1,007,289Charles Garrison Fathman · Stanford University · P01 · FY2006 · AI
AT191: An inhaled & precision RNA therapeutic with pan-variant SARS-CoV-2 efficacy
$1,004,473Ariel Weinberger · Autonomous Therapeutics, Inc. · R44 · FY2025 · AI